Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Aug 22, 2021 3:26pm
163 Views
Post# 33746392

RE:RE:prophetoffacts has found a new word - microglia!

RE:RE:prophetoffacts has found a new word - microglia! pof posted a quote from an NIH scientist, Dr. Daniel Reich who wrote, "The big unmet need in MS is not relapsing or acute MS for which there are already 20 or so treatments. This is really driven by T and B cells as in the reference."

I read about the the treatments for relapsing MS. They are problematic. They have side effects and many deal with relapses after they happen instead of preventing them. I gave my reasons for choosing relapsing MS and not progressive MS as Biaosis's clinical target. Dr. Reich would be the first to understand that the more quickly completed relapsing MS trial would inform physicians about the use of xB3-004 for progressive MS. After all, Dr. Reich is doing the same thing, using IL-1Ra.

I indicated in my article that I wasn't interested in going deep into the science of inflammation. Instead, I wrote about the way Bioasis could approach neuroinflammation and the opportunity that it presents to investors. However, I did provide dozens of links describing many aspects of the science. It's up to investors to go as deep into it as they can or want.

I can assure poof that those links contain thousands of references to the parts played by microglia, T-cells, B-cells, TNFα, IL-6, CD40 ligands, tea leaves and Coco Puffs. There's more of it than poof can eat.

Now, I know he likely didn't read my article, let alone chase down the links I provided. It would stick in his craw to have to read my stuff. He's intellectually lazy and he has an agenda. That's his business. In the days and weeks ahead he's going to learn how much else about Bioasis he's missed.

We live in a time of trolls, of people who get some sort of satisfaction out of being destructive. It's everywhere, and certainly here. It's all about power and damn the truth. Sometimes it's necessary to fight back, and for that, I'm your huckleberry. 

jd
<< Previous
Bullboard Posts
Next >>